title: Is the use of subcutaneous epoetin beta once a week really equivalent to a more frequent administration of the same total dose?
authors.forename: S
authors.initials: S
authors.lastname: Andrulli
authors.forename: M
authors.initials: M
authors.lastname: D'Amico
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin